SUBSCRIBE
SUBSCRIBE

Asia

Business
Takeda Leaps Into NASH With $470M-Plus Deal With HemoShear Therapeutics
Takeda is jumping into the $40B market for NASH and other diseases of the liver with a $470M+ investment into HemoShear Therapeutics.
October 17, 2017
 · 
2 min read
 · 
Alex Keown
Business
Innovent Licenses Use Of Harbour Biomed’s Biologic Drug Discovery Platform
Suzhou’s Innovent Biologics will use a proprietary H2L2 transgenic mouse platform owned by Harbour Biomed of Shanghai to discover new mAbs.
October 16, 2017
 · 
1 min read
Biotech Bay
What Happens When Scientists Change Their R&D Focus
What are the risks and benefits of taking such a step? And what factors are important to consider before doing so?
October 11, 2017
 · 
1 min read
Business
Gentris Corporation And Shanghai Institute Sign MOU For Biomarker Collaboration
October 11, 2017
 · 
1 min read
Tiny KalVista Explodes on $760 Million Deal With Drug Giant Merck & Co.
Deals
Lupin Coughs Up $150 Million Cash for This New Jersey-Based Biopharma
October 11, 2017
 · 
2 min read
Policy
China’s State Council Endorses CFDA’s New Foreign Clinical Trial Data Policies
October 10, 2017
 · 
1 min read
3 Biotechs That Could be Taken Out This Quarter
Business
GlaxoSmithKline’s Pharma Chief Lands Job at Chinese PE Firm
October 10, 2017
 · 
3 min read
Business
Beijing Is Home To Gates-Backed $100 Million Global Health Institute
October 9, 2017
 · 
1 min read
Deals
Week In Review: Fosun Pharma May Pay $350 Million For Second India Pharma Acquisition
October 9, 2017
 · 
1 min read
VBI Vaccines Booming in Kendall Square, Ottawa and Israel
Business
VBI Vaccines Booming in Kendall Square, Ottawa and Israel
October 9, 2017
 · 
6 min read
Load More
PRESS RELEASES
Business
BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer
January 22, 2024
 · 
12 min read
Genetown
Sosei Heptares Webinar Presentation for FY2023 Financial Results
January 22, 2024
 · 
2 min read
InnoCare Announces First Prescription of Tafasitamab in Combination with Lenalidomide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Under Greater Bay Area’s Early Access Program
January 21, 2024
 · 
5 min read
Business
Everest Medicines Announces 2023 Revenue Expected to be Between RMB124 Million and RMB126 Million
January 21, 2024
 · 
3 min read
Biotech Bay
Jacobio Pharma Presents Data of Glecirasib in Patients with Pancreatic Cancer and Other Solid Tumors at the 2024 ASCO GI
January 19, 2024
 · 
4 min read
CARsgen’s Presents Updated Research Results on CT041 at 2024 ASCO GI Meeting
January 19, 2024
 · 
6 min read
Business
Harbour BioMed Announces Positive Profit Alert
January 18, 2024
 · 
3 min read
Deals
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer - January 18, 2024
January 18, 2024
 · 
9 min read
Genetown
Takeda Named Global Top Employer for Seventh Consecutive Year
January 18, 2024
 · 
4 min read
ASCO GI 2024: Golden Biotech’s Antroquinonol Shows Significantly Prolonged Survival in Untreated Metastatic Pancreatic Cancer Patients
January 18, 2024
 · 
5 min read
Drug Development
Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer
January 17, 2024
 · 
8 min read
Deals
Taro Announces Merger Agreement with Sun Pharma
January 17, 2024
 · 
8 min read
Drug Development
Immunity Pharma Announces Positive Top Line Results from Phase 2a Trial with IPL344 in ALS Patients
January 17, 2024
 · 
4 min read
Lunit INSIGHT CXR Excels in Lung Nodule Detection - Exceptional Performance in Head-to-Head Study published in Radiology
January 17, 2024
 · 
3 min read
PNU Researchers Reveal Cutibacterium acnes as a Potential Cause of Lichen Striatus Hypopigmentation
January 17, 2024
 · 
3 min read
NurExone and Inteligex Kick Off Chronic Spinal Cord Injury Research for Multi-Billion Dollar Healthcare Market
January 17, 2024
 · 
5 min read
Drug Development
Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis
January 17, 2024
 · 
5 min read
Business
Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific Region
January 17, 2024
 · 
7 min read
Exero Medical’s Pivotal Clinical Study of xBar Approved by WCG in the US
January 17, 2024
 · 
2 min read
Drug Development
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
January 17, 2024
 · 
5 min read
Load More